MICHAEL LISJAK

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cyclo Therapeutics, Inc.

Filing Date Source Excerpt
2023-01-31 Michael Lisjak 28,614 (10) *

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22